- Home
- NBTX vs PLCE Comparison
NBTX vs PLCE Comparison
Compare NBTX & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- PLCE
- Stock Information
- Founded
- NBTX 2003
- PLCE 1969
- Country
- NBTX France
- PLCE United States
- Employees
- NBTX N/A
- PLCE N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- PLCE Clothing/Shoe/Accessory Stores
- Sector
- NBTX Health Care
- PLCE Consumer Discretionary
- Exchange
- NBTX Nasdaq
- PLCE Nasdaq
- Market Cap
- NBTX 201.9M
- PLCE 174.5M
- IPO Year
- NBTX 2020
- PLCE 1997
- Fundamental
- Price
- NBTX $3.83
- PLCE $16.30
- Analyst Decision
- NBTX Strong Buy
- PLCE Hold
- Analyst Count
- NBTX 2
- PLCE 3
- Target Price
- NBTX $11.50
- PLCE $11.00
- AVG Volume (30 Days)
- NBTX 8.8K
- PLCE 323.7K
- Earning Date
- NBTX 11-26-2024
- PLCE 12-03-2024
- Dividend Yield
- NBTX N/A
- PLCE N/A
- EPS Growth
- NBTX N/A
- PLCE N/A
- EPS
- NBTX N/A
- PLCE N/A
- Revenue
- NBTX $45,220,186.00
- PLCE $1,522,802,000.00
- Revenue This Year
- NBTX N/A
- PLCE N/A
- Revenue Next Year
- NBTX N/A
- PLCE N/A
- P/E Ratio
- NBTX N/A
- PLCE N/A
- Revenue Growth
- NBTX 526.17
- PLCE N/A
- 52 Week Low
- NBTX $3.57
- PLCE $4.77
- 52 Week High
- NBTX $8.96
- PLCE $38.03
- Technical
- Relative Strength Index (RSI)
- NBTX 38.67
- PLCE 62.55
- Support Level
- NBTX $3.57
- PLCE $13.52
- Resistance Level
- NBTX $4.11
- PLCE $16.19
- Average True Range (ATR)
- NBTX 0.28
- PLCE 1.31
- MACD
- NBTX -0.00
- PLCE 0.13
- Stochastic Oscillator
- NBTX 26.31
- PLCE 87.08
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It design, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names.